Assignee
SHANDONG DANHONG PHARMACEUTICAL CO LTD
CN·15 granted patents·1 pending application·7 citations·filing 2014–2022
Top patents by PatentIndex Score
16 records- 0186US11001563B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted May 11, 2021·3 cites·19 claims
- 0284US11505532B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 22, 2022·1 cites·9 claims
- 0379US11897830B2Crystal form and amorphous form of dezocine analogue hydrochlorideSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Feb 13, 2024·0 cites·5 claims
- 0473US11021445B2Carboxylic acid derivative as AT2R receptor antagonistSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 1, 2021·1 cites·20 claims
- 0568US9850251B2Imidazole derivative used as antiviral agent and use therof in preparation of medicamentSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 26, 2017·1 cites·18 claims
- 0667US10633347B2Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 28, 2020·0 cites·10 claims
- 0767US10414718B2Dezocine analogueSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2017·Granted Sep 17, 2019·1 cites·14 claims
- 0866US11339119B2Crystal form and amorphous form of dezocine analogue hydrochlorideSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2018·Granted May 24, 2022·0 cites·7 claims
- 0965US10858322B2Process for preparing 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 8, 2020·0 cites·8 claims
- 1063US12077513B2Process route of compound of formula (IV), crystal form and preparation method thereforSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 3, 2024·0 cites·16 claims
- 1161US10227309B2Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-oneSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·0 cites·9 claims
- 1260US10744109B2Sustained release suspension containing dezocine analogue ester and preparation method thereforSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 18, 2020·0 cites·12 claims
- 1358US11286239B2Angiotensin II receptor 2 antagonist salt form and crystalline form, and preparation method thereforSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 29, 2022·0 cites·22 claims
- 1454US10822365B1SGLTS inhibitor and application thereofSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 3, 2020·0 cites·13 claims
- 1547US10030029B2Imidazole derivative used as antiviral agent and use thereof in preparation of medicamentSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2017·Granted Jul 24, 2018·0 cites·18 claims
- 1643US2022324897A1Crystal form of sglt inhibitor and application thereofSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANDONG DANHONG PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →